The thymus-specific serine protease (PRSS16) gene is highly expressed by cortical epithelial cells in the thymus. 1 The translated protease has been suggested to play a role in positive selection of T cells in the thymus through the alternative antigen-presenting pathway utilised by cortical thymic epithelial cells. 1 The corresponding gene in mice is highly upregulated in rag−/rag− mice, which do not develop functional T cells. 2 Development and maintenance of self-tolerance is essential to avoid the development of autoimmune diseases. One important mechanism is deletion of high avidity autoreactive T cells in the thymus through negative selection. Recently, data have been presented indicating that positive selection also plays a role in establishing tolerance. For example, drug-induced disruption of positive selection of thymocytes causes autoimmunity in mice. 3 This raises the hypothesis that mutations or polymorphisms in genes involved in positive selection might increase susceptibility to autoimmune diseases. Both genetic and environmental factors are involved in the predisposition to autoimmune diseases. In particular, the HLA complex is strongly linked to numerous immune-mediated diseases. This gene complex is located on the short arm of chromosome 6 (6p21.3), where its borders has been extended to encompass 8 Mb of DNA from the centromeric HSET gene to the telomeric HFE gene. The HLA complex is a gene dense region harbouring a large number of genes encoding molecules related to the immune response. 4 With respect to immune-mediated diseases, it has proven to be a difficult task to dissect the HLA-linked disease predisposition in order to identify the genes primarily involved, because of the unusually strong linkage disequilibrium between alleles at loci in the HLA complex.
5 Nevertheless, genes encoding antigen-presenting HLA molecules have been shown to be primarily associated with susceptibility and protection in several immune-mediated diseases.
6 However, several reports suggest that these genes cannot explain the entire genetic predisposition linked to the HLA complex. For example, a gene involved in the development of both type 1 diabetes and celiac disease, marked by microsatellite associations, maps to the extended HLA class I region, and the disease associations were independent of linkage disequilibrium with the primarily involved genes encoding peptide-presenting HLA molecules.
7,8 PRSS16, the subject of the present investigation, is located in the extended class I region, where we previously observed the strongest disease association.
The putative function of PRSS16 and the physical location of the gene suggest that PRSS16 could be involved in the predisposition to immune-mediated diseases. It is generally believed that polymorphisms involved in predisposition to common diseases, like several autoimmune diseases, are characterised by a relatively high frequency (Ͼ1-5%). [9] [10] [11] We therefore aimed at identifying the common polymorphisms in PRSS16 by screening the genetic region covering this gene in 26 healthy individuals.
Genes and Immunity PRSS16 (accession number AAC33563) is located on BAC b24o18 (accession number AL021808), 5.35 Mb telomeric of the DQB1 gene. In this study, we have investigated a genetic region of 11216 bp covering the PRSS16 gene including all 12 exons, introns, the 3ЈUTR and the region upstream of exon 1 (starting −2353 bp upstream of exon 1 in order to ensure that the promoter was completely included). The approach we used was to screen for the presence of polymorphisms by DHPLC 12 of over- lapping PCR fragments (Table 1 ) in a panel of 26 individuals carrying various HLA haplotypes (see Table 3 ). Afterwards, samples found to be heterozygous were sequenced to identify the polymorphisms present. The screening of PRSS16 resulted in the identification of 22 polymorphisms ( Figure 1 and Table 2 ), among these were 20 single nucleotide polymorphisms (SNPs) and two deletions.
The genotyping results of the panel of individuals used to find polymorphisms in the PRSS16 gene are listed in Table 3 . The highest minor allele frequency for the identified polymorphisms was 23%, while the lowest was 2% (Tables 2 and 3) , which also was the detection limit since the screening was done on 52 chromosomes. The average minor allele frequency was 8.5% (±5%). The polymorphisms detected were biallelic, except for one of the 3ЈUTR SNPs, which displayed three alternative bases (A/G/C) in position 7726. All the polymorphisms were in Hardy-Weinberg equilibrium.
Concerning the location of the polymorphisms, six of the SNPs were located in the putative promoter region upstream of exon 1. In order to identify putative transcription binding sites, we scanned the region upstream of exon 1 by MatInspector 2.2 (http://www.gsf.de/cgibin/matsearch.pl) for potential regulatory motifs. 13 Two of the SNPs (at positions −1260 and −1548) could give rise to alternations in potential binding sites for transcription factors. Upstream stimulatory factor (USF) could bind when the −1260 C polymorphism is present, and STATx may bind in the presence of −1548 G, while enhance binding protein (EBP␤) needs C in position −1548 to bind.
Three polymorphisms were identified in the exons; two of which were SNPs. In exon 3 the 1183GϾT leads to the non-conservative amino acid substitution S104I (serine → isoleucine) and in exon 10 the 7023AϾG is silent. Interestingly, a 15-base pair deletion (7548 7563delAGGGAGAGCCAGATT) was found in exon 12 leading to the loss of the amino acids 506-510 (KESQI) of the PRSS16 protein (514 amino acids in total). This deletion was among the most frequent of the detected polymorphisms with a minor allele frequency of 15% in our panel of 26 healthy individuals. Based on the potential for this polymorphism to be of functional interest, we genotyped 261 randomly selected healthy controls from the Norwegian Bone Marrow Donor Registry for this deletion. These individuals had already been genotyped for DQA1 and DQB1 alleles. The allele frequency of the 15 bp deletion was 17% among these random controls which is similar to what we observed in the panel. We estimated the linkage disequilibrium 14 between this PRSS16 deletion and the DQA1-DQB1 haplotypes using haplotype frequencies estimated by an EM algorithm, 15 and the results are shown in Table 4 . The overall linkage disequilibrium (Wn) between the loci was 0.3 ( 2 = 49), and the only significant pairwise linkage disequilibrium was observed between the DQA1*05-DQB1*02 haplotype and the 15 bp deletion (DЈ = 0.3, 2 = 28). The DQA1*05-DQB1*02 haplotype is associated with several autoimmune diseases like celiac disease, type 1 diabetes, Addison's disease and autoimmune thyroid disorders. Whether the PRSS16 deletion detected here influences susceptibility of the DQA1*05-DQB1*02 haplotype remains to be determined.
In conclusion, we have identified several polymorphisms in the gene encoding thymus specific serine protease (PRSS16), which is a putative candidate gene for autoimmune and immune-mediated diseases. Among the discovered polymorphisms, it is likely that some have biological functions, and may influence the risk for some immune-mediated diseases. Hence, several polymorphisms detected in this study might be interesting to investigate for association with autoimmune and inflammatory diseases. A study on the potential association of these polymorphisms in PRSS16 with type 1 diabetes is currently being performed. Amplicons found to be polymorphic by DHPLC were sequenced on an ABI 377 Sequencer using the Big Dye Terminator Cycle Sequencing kit (Applied Biosystems). At least two individuals representing each distinct elution pattern were, if possible, sequenced on both strands, using the PCR primers (Table 1) , to identify the polymorphisms present. Several of the polymorphisms detected by sequencing were confirmed by another detection system. In that case the 26 individuals used in the screening were genotyped for SNPs either by PCRrestriction fragment length analysis (RFLP) if the SNP introduces or removes a site for a restriction enzyme, or alternatively by minisequencing using ABI Prism SNaPshot ddNTP primer extension kit. The PCR primers used refer to the primers listed in Table 1 . Deletions were identified by fragment length analysis on an ABI 377 Sequencer using a dye-labelled forward PCR primer (F) and an unlabelled reverse primer (R). The SNPs marked with * (1332 and 7023) have already been published. The base pair numbers are counted starting with the A in the ATG of the translation start site, therefore all nucleotides upstream are given a negative value. The individual tests for deviation from HWE could be rejected at a 5% level, except SNP 1332 ( 2 = 5.5), however after correcting for multiple tests this is not significant. 
